SKYE

Conviction 0HealthcareScan · Mon, Aug 10, 2026

SKYE$0.5325+2.52%

ResistanceSupportVol 14

Vol MA14 163.82K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Skye Bioscience, Inc.PHARMACEUTICAL PREPARATIONSwww.skyebioscience.com ↗

Price0.5325

Change+2.52%

Gap+3.77%

Rel volume0.93×

Avg volume157.69K

Avg $ vol90.93K

SMA 200.6005

SMA 500.6734

SMA 2000.8853

Price vs 50-20.93%

Price vs 200-39.85%

MA stackbearish

50/200 cross—

Supertrenddown · 0.6399

RSI (14)37

MACD hist-0.01

MACD crossbear · 8d

Stoch %K / %D61 / 55

ADX (14)31

+DI / −DI7 / 43

RSI divergence—

MACD divergenceBullish

ATR %+11.39%

ADR %10.33%

52w high4.75

52w low0.4717

From 52w high-88.79%

Above 52w low+12.89%

New 52w highNo

SqueezeOff

Bollinger width33.40%

%B0.16

Donchian pos61.07%

Donchian high0.6960

Donchian low0.2760

AVWAP (52w high)1.21

vs AVWAP high-56.11%

AVWAP (52w low)0.4823

vs AVWAP low+10.40%

OBV trendDown

Chaikin MF (20)-0.14

Today vs 20d0.93×

Avg vol (14d)163.82K

Avg vol (20d)157.69K

Avg $ vol (20d)90.93K

Market cap18.71M

RS 3m (vs SPY)-47.88%

RS 6m (vs SPY)-49.15%

RS line new highNo

Trend template0/8

Technical rank7.7

1 week-8.85%

1 month-22.83%

3 months-38.28%

6 months-35.01%

1 year-85.00%

YTD-39.36%

P/E-0.33

P/B2.08

P/S—

P/FCF-0.43

EPS-1.41

Div yield—

ROE-620.57%

ROA-288.02%

Debt/Eq0.01

Current1.78

EV/EBITDA-0.19

Gross margin—

Net margin—

Rev growth—

EPS growth-110.50%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value10.68M

Revenue—

Net income-12.51M

Gross profit—

Free cash flow-43.07M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out35.14M

Employees12

ListedMon, Feb 24, 2014

Free float21.44M

Float %61.0%

Short interest1.05M

Days to cover8.0d

Short volume66.7%

Squeeze score53 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank7.7 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.7296

Support0.4130

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in SKYE

All disclosures →

No recent disclosed trades by Congress in SKYE. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in SKYE · 1 buy

Insider	Side	Shares	Value	Traded	Filed
DHILLON PUNIT Chief Executive Officer · Common Stock · 2026-08-07	Grant	1.09M	—	2026-08-07	2026-08-07

SEC filings

EDGAR filings in SKYE · 1 recent

EDGAR →

8-K8-KOther eventTue, Jun 23, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.